These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 7423555

  • 21. Effect of concomitant isoniazid administration on determination of acetylator phenotype by sulphadimidine.
    Zysset T, Peretti E.
    Eur J Clin Pharmacol; 1986; 30(4):463-6. PubMed ID: 3743623
    [Abstract] [Full Text] [Related]

  • 22. Possible optimization of sulphadimidine dosage for acetylator phenotyping.
    Hombhanje F.
    Jpn J Pharmacol; 1991 Aug; 56(4):531-4. PubMed ID: 1744992
    [Abstract] [Full Text] [Related]

  • 23. Clonazepam acetylation in fast and slow acetylators.
    Miller ME, Garland WA, Min BH, Ludwick BT, Ballard RH, Levy RH.
    Clin Pharmacol Ther; 1981 Sep; 30(3):343-7. PubMed ID: 7273597
    [Abstract] [Full Text] [Related]

  • 24. Effect of acetaminophen on sulfamethazine acetylation in male volunteers.
    Tahir IM, Iqbal T, Saleem S, Mehboob H, Akhter N, Riaz M.
    Int J Immunopathol Pharmacol; 2016 Mar; 29(1):17-22. PubMed ID: 26519524
    [Abstract] [Full Text] [Related]

  • 25. Proportions of haemoglobin S in sickle-cell trait.
    Alayash AI.
    Med Lab Sci; 1989 Apr; 46(2):162-3. PubMed ID: 2593776
    [No Abstract] [Full Text] [Related]

  • 26. Acetylator phenotype in psoriasis.
    Jiménez-Nieto LC, Ladero JM, Fernández-Gundín MJ, Robledo A.
    Dermatologica; 1989 Apr; 178(3):136-7. PubMed ID: 2721804
    [Abstract] [Full Text] [Related]

  • 27. A simplified micromethod for the determination of the acetylator phenotype.
    Hoo JJ, Hussein L, Goedde HW.
    J Clin Chem Clin Biochem; 1977 Jun; 15(6):329-31. PubMed ID: 894203
    [Abstract] [Full Text] [Related]

  • 28. Erythrocyte and plasma magnesium in sickle-cell anaemia.
    Olukoga AO, Adewoye HO, Erasmus RT, Adedoyin MA.
    East Afr Med J; 1990 May; 67(5):348-54. PubMed ID: 2390957
    [Abstract] [Full Text] [Related]

  • 29. Acetylator phenotype among individuals with glucose 6-phosphate dehydrogenase variants.
    Jeyakumar LH, French MR.
    Xenobiotica; 1986 Dec; 16(12):1129-32. PubMed ID: 3798960
    [Abstract] [Full Text] [Related]

  • 30. Genetically determined variability in acetylation and oxidation. Therapeutic implications.
    Clark DW.
    Drugs; 1985 Apr; 29(4):342-75. PubMed ID: 2859977
    [Abstract] [Full Text] [Related]

  • 31. Acetylator phenotype determination in the rabbit: sulphamethazine or sulphadiazine, the choice of a substrate.
    du Souich P, Courteau H.
    J Pharm Pharmacol; 1981 Apr; 33(4):261-3. PubMed ID: 6115918
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Oral and dental complications of sickle cell disease in Nigerians.
    Okafor LA, Nonnoo DC, Ojehanon PI, Aikhionbare O.
    Angiology; 1986 Sep; 37(9):672-5. PubMed ID: 3767074
    [Abstract] [Full Text] [Related]

  • 34. Hepatic acetylator polymorphism in breast cancer patients.
    Ladero JM, Fernández MJ, Palmeiro R, Muñoz JJ, Jara C, Lázaro C, Pérez-Manga G.
    Oncology; 1987 Sep; 44(6):341-4. PubMed ID: 3684174
    [Abstract] [Full Text] [Related]

  • 35. Acetylator phenotype and the antihypertensive response to hydralazine.
    Jounela AJ, Pasanen M, Mattila MJ.
    Acta Med Scand; 1975 Apr; 197(4):303-6. PubMed ID: 1136859
    [Abstract] [Full Text] [Related]

  • 36. Evaluation of the sulphadimidine acetylator phenotyping test in patients with reduced renal function.
    Hall S.
    Acta Med Scand; 1981 Apr; 209(6):505-7. PubMed ID: 7257867
    [Abstract] [Full Text] [Related]

  • 37. Drug acetylation and expression of lupus erythematosus.
    Marsden JR, Mason GG, Coburn PR, Rawlins MD, Shuster S.
    Eur J Clin Pharmacol; 1985 Apr; 28(4):387-90. PubMed ID: 4029245
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Comparison between serum and urinary sulphadimidine acetylation as predictors of isoniazid acetylator status in patients with pulmonary tuberculosis.
    Singh SP, Pande JN, Khilnani GC, Kailash S.
    Indian J Chest Dis Allied Sci; 1996 Apr; 38(1):5-11. PubMed ID: 16892742
    [Abstract] [Full Text] [Related]

  • 40. The association of the slow acetylator phenotype with bladder cancer.
    Evans DA, Eze LC, Whibley EJ.
    J Med Genet; 1983 Oct; 20(5):330-3. PubMed ID: 6644762
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.